Expression of Lgr5 in Barrett Esophagus and Early Esophageal Squamous Cell Carcinoma

DING Lijia,CHEN Shiyao,JI Yuan,MA Lili,LIAN Jingjing
DOI: https://doi.org/10.3969/j.issn.1008-7125.2011.06.003
2011-01-01
Abstract:Background: Lgr5,the target gene of Wnt signal pathway,has been identified as a marker of cancer stem cells,and has the potential to be used as a biomarker for Barrett esophagus(BE)-associated dysplasia and esophageal adenocarcinoma(EAC).Aims: To investigate the expression and significance of Lgr5 in BE and early esophageal squamous cell carcinoma(ESCC).Methods: Paraffin-embedded tissues of BE,early ESCC and low-grade esophagitis(20 cases in each group) were collected to examine the expression and distribution of Lgr5 by immunohistochemistry.The immunoreactivity was semi-quantitatively scored based on the percentage of positive cells and intensity of immunostaining.Results: Lgr5 immunostaining distributed in cytoplasm of glandular cells and nucleus of squamous cells.The immunoreactivity score of Lgr5 in glandular epithelium was higher in BE than that in low-grade esophagitis(3.65±1.95 vs.2.55±1.70,P=0.049).While in early ESCC,the immunoreactivity score of Lgr5 was higher in cancerous area than that in paracancerous area(5.39±0.61 vs.3.06±1.06,P=0.000),but no significant differences were found between intraepithelial,intramucosal and submucosal ESCCs(5.00±0.63,5.56±0.53 and 6.00±0.58,P=0.174).Conclusions: Lgr5 might be used as a biomarker for BE and early ESCC.
What problem does this paper attempt to address?